Study Finds That Use Of An Impedance Threshold Device Combined With High Quality CPR And Adherence To American Heart Association Guidelines Increases Neurologically-Intact Survival Rate From In-Hospital Cardiac Arrest To 30 Percent

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MINNEAPOLIS--(BUSINESS WIRE)--A recent study presented by Ken Thigpen, RRT (St. Dominic-Jackson Memorial Hospital; Jackson, Mississippi) at the 2013 American Heart Association (AHA) Scientific Sessions found that use of the ResQPOD® Impedance Threshold Device (ITD), combined with high quality CPR in accordance with AHA Guidelines, helped to increase neurologically-intact survival following in-hospital cardiac arrest from 17.2% in 2005 to 30.1% in 2012 – a 75% improvement (p<0.01). The study assessed the survival impact of the 2005 and 2010 AHA Guidelines, which include ITDs and emphasize the performance of high quality CPR in a medium-size hospital. In addition, 75% of the survivors between 2010 and 2012 had a favorable neurologic recovery (cerebral performance category score of <3). This 30% survival rate is twice the national average for survival following in-hospital cardiac arrest, which is approximately 15% in US hospitals within the Get With The Guidelines Resuscitation Registry.1

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC